Anti-Toxoplasma activity of natural products: A review

Recent Patents on Anti-Infective Drug Discovery

Volumn 9, Issue 3, 2015, Pages 186-194

  Sepúlveda Arias, Juan C ^a   Veloza, Luz A ^a   Mantilla Muriel, Luz E ^a  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

Author keywords

Antiprotozoal agents; Ethnopharmacology; Natural products; Plant extracts; Toxoplasma; Toxoplasmosis

Indexed keywords

ARTEMISIA ANNUA EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; AZADIRACHTA INDICA EXTRACT; COMBRETUM MICRANTHUM EXTRACT; EURYCOMA LONGIFOLIA EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINKGO GLABRA EXTRACT; LIPPIA MULTIFLORA EXTRACT; MELIA AZEDARACH EXTRACT; MYRISTICA FRAGANS EXTRACT; OLEA EUROPAEA EXTRACT; PLANT EXTRACT; PULSATILLA KOREANA EXTRACT; PYRIMETHAMINE; SCUTELLARIA BAICALENSIS EXTRACT; SINOMENIUM ACUTUM EXTRACT; SOPHORA FLAVESCENS EXTRACT; SULFONAMIDE; THYMUS BROUSSONETII EXTRACT; TORILIS JAPONICA EXTRACT; ULMUS MACROCARPA EXTRACT; UNCLASSIFIED DRUG; VERNONIA COLORATA EXTRACT;

ANTIBIOTIC RESISTANCE; ANTITOXOPLASMA ACTIVITY; APIACEAE; ARTICLE; ASTERACEAE; COMBRETACEAE; DRUG ACTIVITY; DRUG HYPERSENSITIVITY; FABACEAE; FRUIT; HUMAN; IC50; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; LAMIACEAE; MALABSORPTION; MELIACEAE; MENISPERMACEAE; MOLECULAR WEIGHT; MYRISTICACEAE; NONHUMAN; OLEACEAE; PLANT LEAF; PLANT ROOT; PLANT STEM; PRIORITY JOURNAL; RANUNCULACEAE; SIMAROUBACEAE; TOXOPLASMA GONDII; TOXOPLASMOSIS; ULMACEAE; VERBENACEAE; ZINGIBERACEAE;

EID: 84930509454     PISSN: 1574891X     EISSN: 22124071     Source Type: Journal    
DOI: 10.2174/1574891X10666150410120321     Document Type: Article

References (46)

1. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol 2009; 39: 895-901.
2. Sepulveda-Arias JC, Gomez-Marin JE, Bobic B, Naranjo-Galvis CA, Djurkovic-Djakovic O. Toxoplasmosis as a travel risk. Travel Med Infect Dis 2014; 12: 592-601.
3. Raffi F, Aboulker JP, Michelet C, Reliquet V, Pelloux H, Huart A, et al. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group. AIDS 1997; 11: 177-84.
4. Rodgers CA, Harris JR. Ocular toxoplasmosis in HIV infection. Int J STD AIDS 1996; 7: 307-9.
5. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: Follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998; 30: 295-300.
6. Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, et al. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrob Agents Chemother 2008; 52: 1269-77.
7. Lilue J, Muller UB, Steinfeldt T, Howard JC. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. Elife 2013; 2: e01298.
8. Rodriguez JB, Szajnman SH. New antibacterials for the treatment of toxoplasmosis: A patent review. Expert Opin Ther Pat 2012; 22: 311-33.
9. Gomes TC, de Andrade Jr HF, Lescano SAZ, Amato-Neto V. In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii. Rev Soc Bras Med Trop 2012; 45: 485-90.
10. Jiménez-González FJ, Veloza LA, Sepúlveda-Arias JC. Anti-infectious activity in plants of the genus Tabebuia. Universitas Scientiarum 2013; 18: 257-67.
11. Taylor PW. Alternative natural sources for a new generation of antibacterial agents. Int J Antimicrob Agents 2013; 42: 195-201.
12. Kayser O, Kiderlen AF, Croft SL. In: Atta ur R, Ed. Natural products as potential antiparasitic drugs. Stud Nat Prod Chem Volume 26, Part G. Elsevier 2002: 779-848.
13. Kayser O, Kiderlen AF, Croft SL. Natural products as antiparasitic drugs. Parasitol Res 2003; 90: S55-62.
14. Torres FAE, Passalacqua TG, Velásquez AMA, Souza RAD, Colepicolo P, Graminha MAS. New drugs with antiprotozoal activity from marine algae: A review. Rev Bras Farmacogn 2014; 24: 265-76.
15. Kayser O, Masihi KN, Kiderlen AF. Natural products and synthetic compounds as immunomodulators. Expert Rev Anti Infect Ther 2003; 1: 319-35.
16. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012; 75: 311-35.
17. Benoit-Vical F, Santillana-Hayat M, Kone-Bamba D, Mallie M, Derouin F. Anti-Toxoplasma activity of vegetal extracts used in West African traditional medicine. Parasite 2000; 7: 3-7.
18. Youn HJ, Lakritz J, Kim DY, Rottinghaus GE, Marsh AE. Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum. Vet Parasitol 2003; 116: 7-14.
19. Youn HJ, Noh JW. Screening of the anticoccidial effects of herb extracts against Eimeria tenella. Vet Parasitol 2001; 96: 257-63.
20. Youn HJ, Lakritz J, Rottinghaus GE, Seo HS, Kim DY, Cho MH, et al. Anti-protozoal efficacy of high performance liquid chromatography fractions of Torilis japonica and Sophora flavescens extracts on Neospora caninum and Toxoplasma gondii. Vet Parasitol 2004; 125: 409-14.
21. Chen SX, Wu L, Jiang XG, Feng YY, Cao JP. Anti-Toxoplasma gondii activity of GAS in vitro. J Ethnopharmacol 2008; 118: 503-7.
22. Choi KM, Gang J, Yun J. Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine. Int J Antimicrob Agents 2008; 32: 360-2.
23. Choi W, Jiang M, Chu J. Antiparasitic effects of Zingiber officinale (Ginger) extract against Toxoplasma gondii. J Appl Biomed 2013; 11: 15-26.
24. de Oliveira TC, Silva DA, Rostkowska C, Bela SR, Ferro EA, Magalhaes PM, et al. Toxoplasma gondii: Effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo. Exp Parasitol 2009; 122: 233-41.
25. Jones-Brando L, D'Angelo J, Posner GH, Yolken R. In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin. Antimicrob Agents Chemother 2006; 50: 4206-8.
26. D'Angelo JG, Bordon C, Posner GH, Yolken R, Jones-Brando L. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother 2009; 63: 146-50.
27. Pifer R, Yarovinsky F. Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol 2011; 27: 388-93.
28. Holfels E, McAuley J, Mack D, Milhous WK, McLeod R. In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother 1994; 38: 1392-6.
29. Sarciron ME, Saccharin C, Petavy AF, Peyron F. Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii. Am J Trop Med Hyg 2000; 62: 73-6.
30. Dahbi A, Bellete B, Flori P, Hssaine A, Elhachimi Y, Raberin H, et al. The effect of essential oils from Thymus broussonetii Boiss on transmission of Toxoplasma gondii cysts in mice. Parasitol Res 2010; 107: 55-8.
31. Ait M'barek L, Ait Mouse H, Jaafari A, Aboufatima R, Benharref A, Kamal M, et al. Cytotoxic effect of essential oil of thyme (Thymus broussonettii) on the IGR-OV1 tumor cells resistant to chemotherapy. Braz J Med Biol Res 2007; 40: 1537-44.
32. Pillai S, Mahmud R, Lee WC, Perumal S. Anti-Parasitic activity of Myristica Fragrans Houtt. Essential oil against Toxoplasma gondii Parasite. APCBEE Procedia 2012; 2: 92-6.
33. De Pablos LM, Gonzalez G, Rodrigues R, Garcia GA, Parra A, Osuna A. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii. J Nat Prod 2010; 73: 831-4.
34. Melo EJT, Vilela KJ, Carvalho CS. Effects of aqueous leaf extracts of Azadirachta indica A. Juss. (neem) and Melia azedarach L. (Santa Barbara or cinnamon) on the intracellular development of Toxoplasma gondii. Rev Bras Pl Med 2011; 13: 15-22.
35. Chan KL, Choo CY, Abdullah NR, Ismail Z. Antiplasmodial studies of Eurycoma longifolia Jack using the lactate dehydrogenase assay of Plasmodium falciparum. J Ethnopharmacol 2004; 92: 223-7.
36. Kavitha N, Noordin R, Chan KL, Sasidharan S. In vitro anti-Toxoplasma gondii activity of root extract/ fractions of Eurycoma longifolia Jack. BMC Complement Altern Med 2012; 12: 91.
37. Yang X, Huang B, Chen J, Huang S, Zheng H, Lun ZR, et al. In vitro effects of aqueous extracts of Astragalus membranaceus and Scutellaria baicalensis GEORGI on Toxoplasma gondii. Parasitol Res 2012; 110: 2221-7.
38. Yang X, Huang S, Chen J, Song N, Wang L, Zhang Z, et al. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UVattenuated Toxoplasma gondii in mouse models. Vaccine 2010; 28: 737-43.
39. Martins A, Vieira H, Gaspar H, Santos S. Marketed marine natural products in the pharmaceutical and cosmeceutical industries: Tips for success. Mar Drugs 2014; 12: 1066-101.
40. Garcia M, Monzote L. Marine products with antiprotozoal activity: A review. Curr Clin Pharmacol 2014; 9: 258-70.
41. Perry TL, Dickerson A, Khan AA, Kondru RK, Beratan DN, Wipf P, et al. New peroxylactones from the Jamaican sponge Plakinastrella onkodes, with inhibitory activity against the AIDS opportunistic parasitic infection Toxoplasma gondii. Tetrahedron 2001; 57: 1483-7.
42. El Sayed KA, Hamann MT, Hashish NE, Shier WT, Kelly M, Khan AA. Antimalarial, antiviral, and antitoxoplasmosis norsesterterpene peroxide acids from the red sea sponge Diacarnus erythraeanus. J Nat Prod 2001; 64: 522-4.
43. Izidoro LFM, Alves LM, Rodrigues VM, Silva DAO, Mineo JR. Bothrops pirajai snake venom L-amino acid oxidase: In vitro effects on infection of Toxoplasma gondii in human foreskin fibroblasts. Braz J Pharmacogn 2011; 21: 477-85.
44. Bastos LM, Junior RJO, Silva DAO, Mineo JR, Vieira CU, Teixeira DNS, et al. Toxoplasma gondii: Effects of neuwiedase, a metalloproteinase from Bothrops neuwiedi snake venom, on the invasion and replication of human fibroblasts in vitro. Exp Parasitol 2008; 120: 391-6.
45. Monzote L. A review of anti-parasitic patents (1988-2008). Rec Pat Antiinfect Drug Discov 2008; 3: 177-91.
46. Angel SO, Matrajt M, Echeverria PC. A review of recent patents on the protozoan parasite HSP90 as a drug target. Rec Pat Biotechnol 2013; 7: 2-8.